Inovio Pharmaceuticals
INO
#9195
Rank
โ‚ฌ0.15 B
Marketcap
1,48ย โ‚ฌ
Share price
-12.17%
Change (1 day)
-31.90%
Change (1 year)

EPS for Inovio Pharmaceuticals (INO)

EPS in 2026 (TTM): -1,56ย โ‚ฌ

According to Inovio Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -1,63ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -1,61ย โ‚ฌ an increase over its 2024 EPS that were of -3,52ย โ‚ฌ.

EPS history for Inovio Pharmaceuticals from 1999 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-1,56ย โ‚ฌ-3.07%
2025-1,61ย โ‚ฌ-54.18%
2024-3,52ย โ‚ฌ-35.14%
2023-5,42ย โ‚ฌ-56.62%
2022-12,50ย โ‚ฌ-19.54%
2021-15,54ย โ‚ฌ35.9%
2020-11,43ย โ‚ฌ-11.57%
2019-12,93ย โ‚ฌ15.24%
2018-11,22ย โ‚ฌ-2.78%
2017-11,54ย โ‚ฌ6.93%
2016-10,79ย โ‚ฌ134.88%
2015-4,59ย โ‚ฌ-29.51%
2014-6,52ย โ‚ฌ-57.34%
2013-15,28ย โ‚ฌ146.55%
2012-6,20ย โ‚ฌ20.83%
2011-5,13ย โ‚ฌ-29.41%
2010-7,27ย โ‚ฌ-48.48%
2009-14,10ย โ‚ฌ10%
2008-12,82ย โ‚ฌ11.11%
2007-11,54ย โ‚ฌ-41.3%
2006-19,66ย โ‚ฌ-66.91%
2005-59,41ย โ‚ฌ110.61%
2004-28,21ย โ‚ฌ-61.63%
2003-73,51ย โ‚ฌ186.67%
2002-25,64ย โ‚ฌ
2001N/A-100%
2000-20,51ย โ‚ฌ-61.58%
1999-53,39ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
7,78ย โ‚ฌ-577.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
5,93ย โ‚ฌ-463.93%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
0,68ย โ‚ฌ-141.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-2,32ย โ‚ฌ 42.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
1,13ย โ‚ฌ-169.15%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
2,85ย โ‚ฌ-274.73%๐Ÿ‡ฌ๐Ÿ‡ง UK
Arrowhead Pharmaceuticals
ARWR
-2,97ย โ‚ฌ 81.97%๐Ÿ‡บ๐Ÿ‡ธ USA